DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Neogen Chemicals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·17 Sept 2026, 1:00 pm

Neogen Chemicals

Neogen Chemicals Limited has announced plans to hold an analyst and institutional investor meeting on September 22, 2026. This event is a standard corporate procedure designed to provide a platform for the company to engage with its financial community and discuss its business strategy.

For investors, this meeting is significant as it offers a chance to gain clarity on the company's future outlook. It allows the management to communicate their vision directly, potentially addressing market expectations and highlighting key growth drivers for the coming period.

Investors should watch for updates on the company's operational roadmap and any guidance provided during the interaction. This information will be crucial for assessing the management's confidence in their future performance and the stock's potential trajectory.